article thumbnail

Collaboration with Janssen and Eli Lilly to address lack of paediatric medications

Pharmaceutical Technology

In recent years, with the advent of biologics and novel therapeutic targets such as anti-TNF, anti-interleukin, and anti-integrin, there has been a steady increase in the number of agents approved to treat inflammatory bowel diseases (IBD), which has provided physicians with an increasing number of options to treat Crohn’s disease (CD).

Medical 59
article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

As per the US Department of Justice, Biogen paid remuneration in the form of training and consulting fees and speaker honoraria, to induce physicians to prescribe the company’s drugs, in violation of the Anti-Kickback Statute.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.”

article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

16 Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions” Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions. Trehalose has a half-life of spontaneous hydrolysis of 6.6

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An He serves as a Board Member on the Board of the Chiesi Group.

article thumbnail

A Leader’s Journey From Surgical Tech Sales To Startup Global Director With Jennifer McLaughlin

Evolve Your Success

We have another special guest and she goes by the name of Jennifer McLaughlin. She’s a certified surgical technologist for many years specializing in mostly orthopedic and neurosurgery. She moved from the clinical side to the sales side of the operating room back in 2014 and joined a major device company.

Sales 52
article thumbnail

Virtual Reality Training For Medical Device Sales Reps With David Howe

Evolve Your Success

— Watch the episode here Listen to the podcast here Virtual Reality Training For Medical Device Sales Reps With David Howe In this episode, we have with us another special guest and he goes by the name of David Howe. Around 2014 and 2015, Oculus launched a kick-starter campaign and created the first mass-market VR headset.